Claritev Corp (CTEV) research
Claritev Corp- Sector
- Health Care
- Last price
- $29.45
- As of
Claritev Corp (CTEV): 4 institutional managers tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-09-15.
As of . Source: SEC EDGAR filings for CTEV. Method and limitations.
Share the CTEV intelligence card
See CTEV live in the terminal
Track CTEV's insider trades, 13F flows, options positioning, and cross asset confluence as they update, on one live board. Free account.
Open the live CTEV terminal, freeActive signals for CTEV
- highINSTITUTIONAL_EXIT
Point72 Asset Management, L.P. cut 56% of CTEV (2026Q2)
- highINSTITUTIONAL_SURGE
CITADEL ADVISORS LLC added +113% to CTEV (2026Q2)
- highINSTITUTIONAL_SURGE
CITADEL ADVISORS LLC added +91% to CTEV (2026Q2)
- highINSTITUTIONAL_EXIT
Point72 Asset Management, L.P. cut 56% of CTEV (2026Q2)
- highINSTITUTIONAL_SURGE
CITADEL ADVISORS LLC added +91% to CTEV (2026Q2)
FREE, NO ACCOUNT
Every signal on CTEV, as it fires
You are seeing 5 of 16 signals recorded on CTEV since 2026-05-16.
The five above all landed on 2026-09-06. The other 11 were recorded on 4 other days. 12 of the 16 are institutional flow rows, which arrive in batches on filing days.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
Largest reported share positions in CTEV (2026Q2)
| Manager / security | Market value | % portfolio | QoQ |
|---|---|---|---|
| RENAISSANCE TECHNOLOGIES LLCCUSIP 62548M209 · 2026Q2 | $1.6M | 0.00% | , |
| Point72 Asset Management, L.P.CUSIP 62548M209 · 2026Q2 | $1.3M | 0.00% | , |
| MILLENNIUM MANAGEMENT LLCCUSIP 62548M209 · 2026Q2 | $339K | 0.00% | , |
| D. E. Shaw & Co., Inc.CUSIP 62548M209 · 2026Q2 | $327K | 0.00% | , |
Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.
Recent SEC filings, CTEV
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
CTEV against its peers
CTEV's operating margin of 3.0% ranks in the 75th percentile of 25 Health Care sub-industry peers, fiscal periods ending between 2025-08-31 and 2026-05-31.
| Metric | CTEV | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | 965M USD | 344M USD | 71 | 25 |
| Gross margin | n/a | 61.0% | n/a | 14 |
| Operating margin | 3.0% | -4.6% | 75 | 25 |
| Net margin | -29.4% | -7.0% | 17 | 25 |
| Return on equity | n/a | -14.1% | n/a | 25 |
| P / E | n/a | 47.6x | n/a | 5 |
Peers (25): CERS, FLGT, SGHT, CCRN, ANGO, EVH, EHAB, SLP, AHCO, VREX, HSTM, TALK, BVS, STAA, CSTL, PRCT, IRMD, TDOC, GDRX, TNDM, USPH, RXST, CERT, OMDA, AMN. Fiscal periods ending between 2025-08-31 and 2026-05-31. Every figure is one full fiscal year read from one annual filing (CTEV: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Related tickers
See more CTEV signals as they fire
Kresmion publishes filings, 13F flows, on-chain whale activity, and cross-asset signals in real time. Open a live board scoped to CTEVand get the insider, 13F, options, and confluence read in one view.